Canadian manufacturers are re-evaluating their dependence on U.S. Markets due to tariffs. The new strategy involves exploring Asian markets, as firms like PNP Pharmaceuticals adapt quickly to the changing landscape.
With about 1.7 million Canadian jobs linked to U.S. Trade, manufacturers must address rising costs while preserving client relationships in America. Executives emphasize the need for stability amidst evolving trade regulations.
Leave a Reply